What Capacity and Cost Won’t Tell You About a Fill-Finish CDMO
Deciding on a Fill-Finish CDMO is a Strategic Decision If capacity and cost are the first metrics you, as the...
Insights from GRAM at CPHI Milan 2026: Navigating the Future of Sterile Manufacturing
What to Expect As biologics manufacturing evolves, Contract Development and Manufacturing Organizations (CDMOs) are becoming increasingly pivotal. At CPHI Milan,...
Inside GRAM’s New Groninger Syringe & Cartridge Filling Line: What Modern Fill-Finish Technology Means for Biologic Drug Manufacturers
As biologic therapies continue to reshape pharmaceutical development, the demands placed on sterile fill-finish manufacturing have never been higher. Pharmaceutical...